Scientists have created the first new anti-malaria drug in quarter of a century in a bid to cut out resistance to existing treatments. Researchers found their new treatment has a “very high cure rate” ...
GanLum achieved a 97.4% PCR-corrected cure rate compared to 94% with standard of care Novartis’ anti-malaria drug could mark the first major advancement in more than 25 years after it showed ...
A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has ...
At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...
Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a crucial structural feature of a key malaria drug target, known as PfATP4, and ...
Investing.com -- 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) stock surged 154% in premarket trading Thursday following the announcement of a partnership with Runway Health to expand access to its ...
Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. Researchers at University of California San Diego ...
Explore the challenges and progress of the Asia-Pacific region in achieving malaria elimination by 2030 amidst funding issues ...
The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the pipeline and it... At the turn of the millennium, a new class of drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results